GMO ETFs | New Options Now Available

In our latest Quarterly Letter, we consider three notable relative equity market underperformers during U.S. growth’s triumphant run: U.S. value, U.S. small, and China.

GMO’s head of Focused Equity, Tom Hancock, and co-head of Asset Allocation, John Thorndike, discussed why diversifying by owning quality and deep value equities can help offset risk in today’s highly concentrated market.

Lucas White delves into the market's reaction to the 2024 election and the motivations of the incoming administration as he considers the future of the IRA and its impact on the clean energy sector.

At GMO’s 2024 Conference, we contemplated the macro fog but concentrated on the fundamentals, showcasing for our clients numerous pockets of value that are being largely overlooked.

GMO has always believed that an objective and disciplined assessment of valuations is critical. We introduce our active, differentiated GMO Value approach, which goes beyond traditional value metrics.

With U.S. Quality (QLTY) and International Quality (QLTI) active ETFs available, we revisit why we believe Quality equity can be a core portfolio holding, resilient to economic headwinds and market drawdowns.

In GMO’s latest Quarterly Valuation Update, we offer our Q3 assessment: Local currency rates and FX screen attractive, while credit is neutral.

Lucas White discusses market sentiment in clean energy, including recent market moves, the divergence between valuations and earnings expectations, and conditions that can lead to such dislocations.